Keyen'e Biotechnology Co., Ltd., Facille, originated from Taiwan, is one of the top ten brands of hyaluronic acid, and is an enterprise that uses CHAPTM patented technology to upgrade Hydmir, and is committed to the production and sales of modified sodium hyaluronate gel for injection

FACILLE is a modified sodium hyaluronate gel for injection from Taiwan, which is produced by the same manufacturer as Hya-Dermis, which has been popular all over the world for nearly ten years. FACILLE has upgraded Hya-Dermis with an exclusive CHAP cross-linked hyaluronic acid platform patent to improve particle tightness and enhance viscoelasticity. In 2014, "FACILLE" officially entered Chinese mainland.

In 2016, Galderma, a subsidiary of Nestlé Skin Health, acted as the sole agent of FACILLE's® ® domestic business. Manufacturer: Keyen's Biotechnology Co., Ltd.

What does Fasri do? To put it simply, Fasli is a safe and highly effective dermal filler, which can be used to fill facial wrinkles and contour, as the hyaluronic acid in the skin gradually loses over time, resulting in dehydration and increased wrinkles.

Fasli's exclusive CHAP cross-linking hyaluronic acid platform patent, that is, the use of a small amount of cross-linking agent can achieve high efficiency, so that Fasli has two unique advantages that other brands cannot match. First, the innovative crystal form hyaluronic acid can create excellent support and is not easy to shift; The second is the unique three-dimensional barrier structure, which makes the resistance to enzyme degradation stronger and the shaping effect more durable.

These two unique advantages have made Fasli a popular injectable microplastic surgery aesthetic product all over the world. At the same time, Fasli has passed clinical trials in many hospitals on both sides of the Taiwan Strait to verify that the products are safe and effective. All these advantages have made Fasli highly praised by users around the world.